293 related articles for article (PubMed ID: 12038225)
1. [Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].
van Wijngaarden P; Janssen JA; de Man RA
Ned Tijdschr Geneeskd; 2002 May; 146(18):859-62. PubMed ID: 12038225
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
[TBL] [Abstract][Full Text] [Related]
3. Hepatoma with severe non-islet cell tumor hypoglycemia.
Tietge UJ; Schöfl C; Ocran KW; Wagner S; Böker KH; Brabant G; Zapf J; Manns MP
Am J Gastroenterol; 1998 Jun; 93(6):997-1000. PubMed ID: 9647037
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin.
Kampitak T
Cancer Chemother Pharmacol; 2008 Oct; 62(5):929-30. PubMed ID: 18278497
[No Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma arising from ectopic liver tissue in the spleen producing insulin-like growth factor II.
Matsuyama M; Sugiura S; Kakita A; Sato Y; Kuroda M
Pathol Res Pract; 2011 Feb; 207(2):124-6. PubMed ID: 20943327
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
[TBL] [Abstract][Full Text] [Related]
7. Non islet cell tumor hypoglycaemia in a metastatic Leydig cell tumor.
Mukherjee S; Diver M; Weston PJ
Acta Oncol; 2005; 44(7):761-3. PubMed ID: 16227169
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.
Teale JD; Wark G
Clin Endocrinol (Oxf); 2004 Apr; 60(4):457-60. PubMed ID: 15049960
[TBL] [Abstract][Full Text] [Related]
9. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II.
Hino N; Nakagawa Y; Ikushima Y; Yoshida M; Tsuyuguchi M
Breast Cancer; 2010 Apr; 17(2):142-5. PubMed ID: 19259766
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
Wu JC; Daughaday WH; Lee SD; Hsiao TS; Chou CK; Lin HD; Tsai YT; Chiang BN
J Lab Clin Med; 1988 Nov; 112(5):589-94. PubMed ID: 2460570
[TBL] [Abstract][Full Text] [Related]
11. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
Hunter SJ; Daughaday WH; Callender ME; McKnight JA; McIlrath EM; Teale JD; Atkinson AB
Clin Endocrinol (Oxf); 1994 Sep; 41(3):397-401; discussion 402. PubMed ID: 7525121
[TBL] [Abstract][Full Text] [Related]
12. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
Hoff AO; Vassilopoulou-Sellin R
Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
[TBL] [Abstract][Full Text] [Related]
13. Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors.
Møller N; Frystyk J; Skjaerbaek C; Pedersen HB; Christensen C; Schmitz O; Gee A; Gjedde A; Zapf J; Orskov H
Diabetologia; 1996 Dec; 39(12):1534-5. PubMed ID: 8960839
[No Abstract] [Full Text] [Related]
14. A case of haemangiopericytoma-associated hypoglycaemia: Beneficial effect of treatment with radiotherapy.
Soran H; Younis N; Joseph F; Hayat Z; Zakhour H; Scott A
Int J Clin Pract; 2006 Oct; 60(10):1319-22. PubMed ID: 16981978
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
Yamaguchi M; Tate G; Yoshizawa Y; Midorikawa T; Sanada Y; Kumada K
Surg Today; 2002; 32(11):1008-11. PubMed ID: 12444442
[TBL] [Abstract][Full Text] [Related]
16. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
17. [Production of insulin-like growth factor-II in hepatocellular carcinoma with recurrent hypoglycemia: a case report].
Nakata R; Kadoya H; Sugimura N; Katsuno T; Aomatsu K; Hayakawa T; Uchida-Kobayashi S; Arakawa T; Miwa H
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(2):256-263. PubMed ID: 28163291
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma with non-islet cell tumor hypoglycemia.
Fernando HS; Hawkyard SJ; Poon P; Musa M
Int J Urol; 2006 Jul; 13(7):985-6. PubMed ID: 16882067
[TBL] [Abstract][Full Text] [Related]
19. Tumor associated hypoglycemia and elevated serum nonsuppressible insulin-like activity.
Castro A; Florez L; Rozanski JJ; Mintz DH
J Fla Med Assoc; 1978 Jun; 65(6):421-4. PubMed ID: 207814
[No Abstract] [Full Text] [Related]
20. Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.
van Veggel KM; Huits RM; Donker GH; Lentjes EG; van Doorn J
Growth Horm IGF Res; 2014 Dec; 24(6):233-8. PubMed ID: 25174810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
